“The upper bounds of damages against Pfizer would be $3.6 trillion dollars. And obviously, Pfizer’s not worth $3.6 trillion dollars. That company would have to be seized in bankruptcy, its assets distributed and sold off, and I think that’s an appropriate end for that company. So I’m doing everything I can to get there.” After…

“The upper bounds of damages against Pfizer would be $3.6 trillion dollars. And obviously, Pfizer’s not worth $3.6 trillion dollars. That company would have to be seized in bankruptcy, its assets distributed and sold off, and I think that’s an appropriate end for that company. So I’m doing everything I can to get there.” After…

“The upper bounds of damages against Pfizer would be $3.6 trillion dollars. And obviously, Pfizer’s not worth $3.6 trillion dollars. That company would have to be seized in bankruptcy, its assets distributed and sold off, and I think that’s an appropriate end for that company. So I’m doing everything I can to get there.” After…

“The upper bounds of damages against Pfizer would be $3.6 trillion dollars. And obviously, Pfizer’s not worth $3.6 trillion dollars. That company would have to be seized in bankruptcy, its assets distributed and sold off, and I think that’s an appropriate end for that company. So I’m doing everything I can to get there.” After…

The legal case brought by a whistleblower from Pfizer’s COVID-19 vaccine trial has been dismissed by a judge. Brook Jackson, who worked for Pfizer contractor Ventavia Research Group, did not prove violations of the False Claims Act, U.S. District Judge Michael Truncale ruled. Jackson sued Ventavia, Pfizer, and another organization involved in the vaccine trial…

In Beaumont, Texas, attorneys for a whistleblower alleging violations occurred during the Pfizer–BioNTech COVID-19 vaccine clinical trial argued in federal court on March 1 that their case should advance to the discovery phase. Attorneys for the defendants—Pfizer and two subcontractors, Ventavia Research Group and ICON—tried to convince the judge to dismiss the case. If successful,…

A hearing is scheduled to take place in a legal case brought by a whistleblower who confirmed that violations occurred during the Pfizer-BioNTech COVID-19 vaccine clinical trial. The company Ventavia failed to properly report adverse events and keep all participants blinded, according to internal communications revealed by Brook Jackson, the whistleblower. Pfizer paid ICON, a clinical…